UnitedHealth Group (UNH) earnings Q3 2026
UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…
Japan wants a pharma boom. It needs a new strategy.
Japan wants pharmaceuticals and advanced medicine to drive its next phase of economic growth. But achieving that goal…
Major change for users of diltiazem 360 mg controlled-release capsules
A widely used heart medication is facing a supply change in Australia, with its 360 mg controlled-release capsule…
Novo’s Wegovy pill improves weight loss after switch from injections
People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
Ozempic counterfeit ring charges against Indian nationals unsealed
Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…
Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Trump administration removes around 760,000 Obamacare enrollments
An Obamacare sign is displayed outside an insurance agency on Nov. 12, 2025, in Miami. Joe Raedle |…
Eli Lilly CEO David Ricks discusses GLP-1s and Medicare coverage
Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…
Lilly is ramping up future manufacturing for Foundayo obesity pill
Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…
Novo Nordisk rebrands to ‘Novo’ under CEO Mike Doustdar
Novo Nordisk on Monday said it is rebranding its name to “Novo” and updating its corporate culture, as…
Gifts from pharma companies keep on giving, a new study finds
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Meet Ottava, J&J’s surgical robot leading the healthcare giant into a lucrative new market
Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…